Two molecules, one name
Published chemistry, not a measurement from any lot.
TB-500 is a synthetic N-acetylated heptapeptide, Ac-Leu-Lys-Lys-Thr-Glu-Thr-Gln, which corresponds to residues 17 to 23 of thymosin beta-4. Thymosin beta-4 is something else: a naturally occurring 43-residue actin-binding protein. The FDA's Global Substance Registration System registers them as separate substances, TB-500 under UNII QHK6Z47GTG and thymosin beta-4 under UNII 549LM7U24W, and they differ by roughly 4,000 g/mol.
That is the whole problem with this material, and it is not subtle. The heptapeptide is about 889 g/mol and the protein about 4,963. A mass spectrometer tells them apart instantly, and no purity figure ever will. Marogen's catalog name for the vial reads “TB-500 (Thymosin Beta-4)”, and the site flags openly that which substance is supplied needs confirming against the certificate for the lot in hand.
- CAS
- 885340-08-9 · awaiting confirmation
- Molecular formula
- C38H68N10O14
- Molecular weight
- 889.0 g/mol
- Sequence
- Ac-LKKTETQ
- Residues
- 7
- Also searched as
- TB500, TB 500, Thymosin beta-4 fragment
Compiled from public chemistry records (PubChem, FDA GSRS, UniProt). Values marked “awaiting confirmation” are not yet confirmed by Marogen. The certificate for a lot is the authority for every number on it. See the analytical reference table.
Formats Marogen stocks
Every catalog listing that contains a TB-500 component, with sizes and SKUs.
The single-component vial comes in two sizes and is the only listing where the TB-500 component is alone. Everything else is a blend: two vial blends with BPC-157, the GLOW and KLOW vials, two nasal sprays, and two of the six prefilled research pens. The Wolverine pen pairs it with BPC-157; the KLOW pen adds GHK-Cu and KPV.
Three of those listings say “TB-500 fragment” in the product name rather than “TB-500”, which is a more accurate description of the heptapeptide and a useful signal on a quote. Marogen does not publish per-component concentrations or fill volumes for the pens, so ask for those figures on the quote.
| Listing | Form | Sizes | SKU | Documentation |
|---|---|---|---|---|
| TB-500 (Thymosin Beta-4) | Lyophilized powder, sealed vial | 5 mg10 mg | TB500-5MGTB500-10MG | Lot TB10-0803 on file |
| BPC-157/TB-500 Blend | Lyophilized powder, sealed vial | 10/10 mg | BPCTB | Lot BPCTB20-1008 on file |
| Wolverine | Lyophilized powder, sealed vial | 10 mg20 mg | WOLV-10MGWOLV-20MG | Lot UNBT10 on file |
| GLOW 70 mg: GHK-Cu / BPC-157 / TB-500 | Lyophilized powder, sealed vial | 70 mg | GLOW | Lot GLOW70-0803 on file |
| KLOW 80 mg: GHK-Cu / BPC-157 / TB-500 / KPV | Lyophilized powder, sealed vial | 80 mg | KLOW | Lot KLOW80-1008 on file |
| Wolverine BPC-157 + TB-500 Fragment | 15 mL metered nasal spray | 15 mg + 15 mg / 15 mL | SNS-WOLV-30 | Not yet published |
| GLOW BPC-157 + TB-500 Fragment + GHK-Cu | 15 mL metered nasal spray | 15 mg + 15 mg + 75 mg / 15 mL | SNS-GLOW-105 | Not yet published |
| Wolverine | Prefilled research pen | 10+10 mg | PEN-WOLV-20 | Not yet published |
| KLOW | Prefilled research pen | Not published | PEN-KLOW | Not yet published |
9 catalog listings are covered here. Sizes, SKUs and documentation status are read from the catalog at build time. Blends contain more than one molecule, so only single-component listings behave as a single-analyte standard. Pricing is per account: see wholesale pricing.
What a certificate of analysis must show
One field on this certificate matters more than the rest.
For this material, the mass-spectrometry line is the certificate. If the observed mass sits near 890 for the singly charged ion or 445.5 for the doubly charged ion, the vial holds the heptapeptide. If it sits in the thousands across several charge states, it holds the protein. Everything else on the page is secondary to that one measurement.
Marogen's published Wolverine certificate, lot UNBT10, is a live example of why this matters. It names “Thymosin Beta-4” and reports a net content of 11.72 mg for that component, while the catalog describes the shorter TB-500 fragment. The site flags the discrepancy on the product page rather than papering over it, which is the correct handling: the certificate is the authority, and the open question is stated instead of being resolved by assumption.
| Field | What it has to say for TB-500 |
|---|---|
| Which substance | TB-500 heptapeptide or full-length thymosin beta-4, named explicitly. This is the field that matters |
| Identity | Observed against calculated mass: near m/z 890.0 for [M+H]+ or 445.5 for [M+2H]2+ if the heptapeptide, from 889 g/mol |
| N-terminus | Whether the leucine is acetylated. Ac-LKKTETQ against LKKTETQ is a 42 Da difference |
| Sequence | LKKTETQ, seven residues, stated as the expected sequence. The protein would be 43 |
| Purity | Area percent by reverse-phase HPLC with wavelength and gradient stated. The heptapeptide has no aromatic residue, so backbone absorbance is all there is |
| Content | Milligrams actually present, separate from purity. UNBT10 reports 11.72 mg for this component |
| Salt form | Free peptide, acetate or trifluoroacetate |
| Per component, for blends | Mass, purity and content for each molecule separately |
Storage and handling in the lab
The heptapeptide has no methionine and no cysteine, so oxidation is less of a concern than it is for several other catalog materials. The threonine and glutamine residues bring their own slow routes, with glutamine deamidation the one most likely to show as a small satellite peak after a long time in solution. Marogen does not publish per-material storage conditions, so confirm the condition for your lot with the wholesale team. The points below are general laboratory practice, not a Marogen specification.
- Keep the lyophilized solid sealed, dry and cold, and bring the vial to room temperature before opening so moisture does not condense into the powder.
- Make up small aqueous stocks rather than one large one, and keep them cold. Deamidation is slow, but it is cumulative.
- For blends and pens you are storing several molecules under one condition, and the least stable component sets the limit.
- Record the lot number and the substance the certificate names, not just the product name on the box.
Telling it apart from related compounds
Every identification question for this material comes back to length. The heptapeptide, the acetylated heptapeptide, the full protein and the various blends all travel under the TB-500 name somewhere in the market, and mass is the only honest arbiter. Sequence claims on a datasheet are not evidence; a mass spectrum is.
| Material | How it differs and how to check |
|---|---|
| Thymosin beta-4, full length | 43 residues, roughly 4,963 g/mol, UNII 549LM7U24W. Multiple high charge states on a mass spectrum. Not the same substance as TB-500 |
| LKKTETQ without acetyl | 42 Da lighter than Ac-LKKTETQ, near 847 g/mol. Different retention, different calculated mass |
| Wolverine, GLOW, KLOW | Blends containing the TB-500 component plus two to four others. Several masses in one chromatogram |
| Deamidated heptapeptide | Roughly 1 Da heavier from glutamine deamidation. A satellite peak beside the main one after time in solution |
What the published literature measured
Almost all of the published measurement is on the 43-residue protein, not on the heptapeptide sold as TB-500. That asymmetry is the honest summary of the literature, and the three papers below are where the actin-binding work and the LKKTETQ motif actually come from.
Safer D, Elzinga M, Nachmias VT. Journal of Biological Chemistry 1991; 266:4029-4032.
Showed by sequencing and co-chromatography that the actin-sequestering peptide then called Fx is thymosin beta-4, establishing the parent protein's identity.
Van Troys M, Dewitte D, Goethals M, et al.. The EMBO Journal 1996; 15:201-210.
Mapped the actin-binding site of thymosin beta-4 by mutational analysis, which is where the LKKTETQ motif sold as TB-500 comes from.
Goldstein AL, Hannappel E, Kleinman HK. Trends in Molecular Medicine 2005; 11:421-429.
Reviewed the actin-sequestering measurements for the 43-residue protein and the separate experiments reported for its short fragments.
Wholesale availability
All nine listings containing a TB-500 component are supplied wholesale, priced per account rather than from a public list. If which substance you receive matters to your method, say so in the pricing request: the quote is where the lot's certificate and the substance it names get confirmed before you commit.
Apply for wholesale pricing
List the materials, sizes and units you need, or ask about the range, and say a little about the business. Pricing is set per account and confirmed on every quote, with the lot’s documentation status stated for each line.
Questions
Are TB-500 and thymosin beta-4 the same thing?
No. TB-500 is a synthetic N-acetylated heptapeptide, Ac-Leu-Lys-Lys-Thr-Glu-Thr-Gln, matching residues 17 to 23 of thymosin beta-4, at roughly 889 g/mol. Thymosin beta-4 is the full 43-residue actin-binding protein at roughly 4,963 g/mol. The FDA's substance registry lists them under separate identifiers. They are routinely sold under one name, which is why the mass on the certificate is the only reliable check.
How do I tell which one is in a vial?
Read the mass-spectrometry line on the certificate of analysis. The heptapeptide shows near m/z 890.0 as the singly charged ion and 445.5 as the doubly charged ion. The full protein appears as a series of higher charge states in the thousands. A purity percentage, a sequence printed on a datasheet and a product name cannot distinguish them; an observed mass can, in one line.
Which Marogen products contain a TB-500 component?
Nine listings: the single-component vial in two sizes, the BPC-157 and TB-500 blend vial, the Wolverine, GLOW and KLOW vials, the Wolverine and GLOW nasal sprays, and the Wolverine and KLOW pens. Three name it as a TB-500 fragment, which is the more accurate description.
What does the published Wolverine certificate say?
Lot UNBT10, a 20 mg Wolverine vial tested by Freedom Diagnostics, reports 99.75 percent purity by HPLC and net contents of 12.85 mg for BPC-157 and 11.72 mg for the component it names as Thymosin Beta-4. The catalog describes the shorter TB-500 fragment, so the certificate and the catalog disagree. Marogen flags that open question on the product page rather than resolving it by assumption.
Where does Marogen publish lot certificates?
In the certificate library at marogenbio.com/coa, filed under the lot number printed on the label, with a lookup at marogenbio.com/lot that reads the number printed on the vial. Coverage across the catalog is partial and the status is stated on every material page. Wolverine lot UNBT10 is published; the single-component TB-500 vial has no published certificate at present.
Research use only. This guide describes materials supplied for in-vitro research and analytical method development. Nothing here is dosing, administration or use information, and no product on this site is offered for human or animal consumption. See the research use policy.